Florio T, Grimaldi M, Scorziello A, Salmona M, Bugiani O, Tagliavini F, Forloni G, Schettini G
Istituto di Farmacologia, Facoltà di Medicina, Università di Genova, Italy.
Biochem Biophys Res Commun. 1996 Nov 12;228(2):397-405. doi: 10.1006/bbrc.1996.1673.
The infectious prion protein (PrPSc) is the etiologic agent of transmissible neurodegenerative conditions such as scrapie or Creutzfeldt-Jakob disease. Its fragment 106-126 (PrP106-126) has been reported to maintain most of the pathological features of PrPSc. We report here the intracellular mechanisms mediating the proliferative effects of PrP106-126 on rat cortical type I astrocytes. The proliferative effects of PrP106-126 started after 24h of treatment and lasted up to 9 days and was antagonized by the L-type voltage-sensitive calcium channel blocker nicardipine. Microfluorimetric studies showed that PrP106-126 caused a rapid increase in the [Ca+2]i. This effect was prevented by nicardipine, or by Ca(+2)-free conditions, showing that the PrP106-126 enhances [Ca+2]i mobilizing Ca+2 from the extracellular environment. Moreover, binding studies demonstrated a direct interference of PrP106-126 with the dihydropyridine binding site. This is the first evidence that a prion protein fragment directly stimulates the proliferation of astrocytes via an increase in [Ca+2]i through the L-type voltage-sensitive calcium channels.
传染性朊病毒蛋白(PrPSc)是诸如羊瘙痒症或克雅氏病等可传播神经退行性疾病的病原体。据报道,其106 - 126片段(PrP106 - 126)保留了PrPSc的大部分病理特征。我们在此报告介导PrP106 - 126对大鼠皮质I型星形胶质细胞增殖作用的细胞内机制。PrP106 - 126的增殖作用在处理24小时后开始,持续长达9天,并被L型电压敏感性钙通道阻滞剂尼卡地平所拮抗。微量荧光测定研究表明,PrP106 - 126导致细胞内钙离子浓度([Ca+2]i)迅速升高。尼卡地平或无钙条件可阻止这种效应,表明PrP106 - 126通过从细胞外环境动员钙离子来提高[Ca+2]i。此外,结合研究证明PrP106 - 126与二氢吡啶结合位点存在直接干扰。这是朊病毒蛋白片段通过L型电压敏感性钙通道增加[Ca+2]i直接刺激星形胶质细胞增殖的首个证据。